Sofosbuvir and Ribavirin for 24 Weeks Is An Effective Treatment Option for Recurrent Hepatitis C Infection After Living Donor Liver Transplantation.
| Image |  |
|---|---|
| Description | scientific article published on 28 June 2017 |
| Author/s |
author: Anil C Anand |
| Publication date | June 28, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |